With the constant and increasingly popular hype of the iPhone (News - Alert) and other smartphone devices, as well as the continued expansion of mobile devices rising as a dominant communication platform, SMBs and large enterprises in the telecom industry are trying to get their hands on as many new ventures as they can.

So, it came as no surprise when Zargis Medical Corp., a subsidiary of Speedus Corp. and a spin-off from Siemens (News - Alert) Corporate Research, announced that it was approved as a new Apple (News - Alert) iPhone developer in efforts to expand their customer base and product lines.

Additionally, the company has begun developing medical diagnostic support software and related peripherals for the iPhone and other leading smartphones.

Since the mobile segment – especially smartphones – have become such a lucrative outlet for service providers and other telecom companies, Zargis has identified the mobile device market as a way to introduce the company’s telemedicine and diagnostic software initiatives.

Zargis CEO John Kallassy said that the future of healthcare delivery is about connectivity and mobility.

“Zargis' expertise in computer-aided auscultation and our advanced medical software platform positions us perfectly to create diagnostic software and peripherals that are a natural fit for smartphones,” Kallassy said. “We intend to improve healthcare efficiency by helping clinicians bring medical technology to the patient, rather than the other way around.”

With its team of experienced developer's, the company plans to leverage the smartphone platform as a mobile hub between medical device peripherals and computer-aided diagnostic support located either locally or remotely, company officials said.

And, research in the smartphone market backs up Zargis’ attempts to branch out its software applications into the smart segment. 

Manhattan Research released a report that started roughly 64 percent of doctors own smartphones, which is double the amount of medical smartphone users eight years ago. The research also predicted the figure to increase to 81 percent by 2012.